Why Do Genetic and Lab Findings Often Mismatch in VTE Anticoagulant Defect Diagnosis?
Journal of Thrombosis and Haemostasis (JTH) shared an insightful post on LinkedIn:
“Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism.
In VTE patients, genotype-phenotype concordance for natural anticoagulant defects is far from absolute.
This study reveals that genetic variants may present with normal plasma activity, while reduced activity can occur without detectable variants – underscoring the diagnostic limitations of relying solely on either approach.”
Read the paper here.
Article: Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism
Authors: Christine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, Andreas Verstraete, Sarissa Baert, Cyrielle Kint, Mirjam Kruijt, Renee Ruhaak, Veerle Labarque, Thomas Vanassche, Peter Verhamme, Kathelijne peerlinck, Kathleen Freson
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis